VacciNEWS

GHP News

View all

Literature update ViVa week 38-2026

23 September, 2026

12 min read

ViVa 37– Global outbreak status (16th September 2026)

16 September, 2026

6 min read

Literature update ViVa week 37-2026

16 September, 2026

5 min read

Literature update ViVa week 35-2026

3 September, 2026

8 min read

ViVa 34– Global outbreak status (27th August 2026)

27 August, 2026

3 min read

Pneumococcal vaccines: Brands, manufacturers, and age indications

19 August, 2026

11 min read

A big hand, foot and mouth disease season in APAC

13 August, 2026

6 min read

ViVa 32– Global outbreak status (12th August 2026)

12 August, 2026

5 min read

Longevity, vaccination, and the limits of human lifespan

12 August, 2026

5 min read

ViVa 31– Outbreak news status summary (05th August 2026)

5 August, 2026

3 min read

The next pandemic is not a matter of if, but when

5 August, 2026

9 min read

ViVa 30– Outbreak News (29th July 2026)

29 July, 2026

6 min read

Microbiology and infectious diseases in numbers

29 July, 2026

4 min read

Literature update ViVa week 30-2026

29 July, 2026

10 min read

Reassessment: Qdenga and the seronegative risk signal

29 July, 2026

3 min read

vaccines don’t trigger flares in patient with autoimmune disease — German claims study delivers reassurance

27 July, 2026

2 min read

The PPP of dengue vaccines: past, present, and pipeline

23 July, 2026

12 min read

Human pertussis challenge study identifies plausible correlates of protection—but only in a whole-cell-primed generation

22 July, 2026

2 min read

Shingles risk in younger adults with chronic conditions rivals that of healthy adults in their 50s

21 July, 2026

2 min read

Subacute sclerosing panencephalitis: The devastating long-term risk of measles infection in young children

21 July, 2026

3 min read

Needle-free pan-sarbecovirus vaccine clears phase 1 safety milestone, but broad protection remains unproven

21 July, 2026

2 min read

National Academy of Medicine (NAM) – is big tech partnership a bridge to reliable health information, or a reputational risk?

21 July, 2026

2 min read

Vaccines return $16 for every $1 invested, but the era of dramatic cost savings may be fading

21 July, 2026

2 min read

Dual influenza subtype positivity is linked to more severe pneumonia, but is it true co-infection or a dataset artifact?

21 July, 2026

2 min read

Old epilepsy drug repurposed as a low-cost metabolic vaccine booster increases T-cell responses 10-fold in a human trial

21 July, 2026

2 min read

ViVa news week 29 (July 20, 2026)

20 July, 2026

6 min read

Global child vaccination rates tick up, but millions still left Unprotected — WHO/UNICEF

16 July, 2026

3 min read

Measles masquerading as “just fever” in nearly a third of Tanzanian cases — no rash, no suspicion, worse outcomes, and a diagnosis missed for two months

15 July, 2026

2 min read

ViVa 28 feature: Universal influenza vaccines – more than just “broader immunity”

15 July, 2026

5 min read

Outbreak News

View all

The silent spread of Oropouche virus

17 April, 2025

4 min read

The enduring legacy of a forgotten killer and its modern-day threat

3 October, 2024

6 min read

Mpox: African scientists at the forefront of a global health crisis

2 October, 2024

4 min read

Vaccines don’t cause autism, but the lie won’t die—in fact, it’s getting worse

11 June, 2024

4 min read

WHO South-East Asia Regional Strategy for the prevention and control of Nipah virus infection 2023–2030

10 November, 2023

3 min read

Italy: West Nile virus cases soar to 283

4 October, 2023

3 min read

Avian flu reappears in Cambodia, UN health agency warns

27 February, 2023

4 min read

Earthquakes in Türkiye and Syria: infectious diseases expected to be a concern in two to four weeks

21 February, 2023

3 min read

Equatorial Guinea confirms first Marburg virus disease outbreak

15 February, 2023

2 min read

Malaria: Three-dose Plasmodium falciparum sporozoite (PfSPZ) vaccine shows safety, efficacy in Burkina Faso adults

12 January, 2023

4 min read

Uganda declares Ebola Virus Disease outbreak

21 September, 2022

2 min read

Travel alert for Chikungunya Virus

30 August, 2022

2 min read

New York detects vaccine-derived polio case

22 July, 2022

3 min read

Ghana declares first-ever outbreak of Marburg virus disease

22 July, 2022

4 min read

Vaccine-derived poliovirus Type 2 in London’s environmental samples

14 July, 2022

5 min read

Confirmed monkeypox case in North America

23 May, 2022

3 min read

Smallpox vaccine, IMVANEX, to be supplied to unknown European country in response to monkeypox

23 May, 2022

2 min read

Vaccine-preventable disease outbreaks on the rise in Africa

29 April, 2022

4 min read

Multi-Country – Acute, severe hepatitis of unknown origin in children

25 April, 2022

7 min read

Cholera and measles kill hundreds, while polio reappears in Congo

New Ebola outbreak declared in the Democratic Republic of Congo

25 April, 2022

3 min read

Experts warn of possible XE subvariant outbreak in Japan

18 April, 2022

2 min read

Europe on alert as UK investigates mysterious cases of severe hepatitis in young children

18 April, 2022

3 min read

Why US-Universities Battle Meningitis Outbreaks

18 April, 2022

4 min read

Pertussis outbreak in indigenous population in Colombia

23 March, 2022

3 min read

Kenya takes a strong stand in Covid-19 vaccinations to minimize the spread of the disease

15 March, 2022

2 min read

Nosocomial Mycobacterioides chelonae Outbreak in England

14 March, 2022

3 min read

Japanese encephalitis virus situation declared a Communicable Disease Incident of National Significance

8 March, 2022

4 min read

Latest Science

View all

Literature update ViVa week 38-2026

23 September, 2026

12 min read

ViVa 38– Global outbreak status (23rd September 2026)

23 September, 2026

3 min read

Feature: The 2026 vaccine licenses: influenza drives a new platform era

23 September, 2026

11 min read

ViVa 37 Feature: Influenza vaccines for the 2026–2027 respiratory season

16 September, 2026

11 min read

Literature update ViVa week 36-2026

9 September, 2026

8 min read

ViVa 36– Global outbreak status (09th September 2026)

9 September, 2026

5 min read

Autumn started – time to review your vaccination card

9 September, 2026

8 min read

Literature update ViVa week 35-2026

3 September, 2026

8 min read

Closing the gap: The race for a Bundibugyo Ebola vaccine

3 September, 2026

10 min read

The capsule that vanished: How beating Hib unmasked the full Haemophilus influenzae problem

27 August, 2026

13 min read

Literature update ViVa week 34-2026

27 August, 2026

14 min read

ViVa 33– Global outbreak status (19th August 2026)

19 August, 2026

7 min read

Literature update ViVa week 33-2026

19 August, 2026

8 min read

Pneumococcal vaccines: Brands, manufacturers, and age indications

19 August, 2026

11 min read

Literature update ViVa week 32-2026

12 August, 2026

8 min read

Literature update ViVa week 31-2026

5 August, 2026

10 min read

The next pandemic is not a matter of if, but when

5 August, 2026

9 min read

Microbiology and infectious diseases in numbers

29 July, 2026

4 min read

Literature update ViVa week 30-2026

29 July, 2026

10 min read

Reassessment: Qdenga and the seronegative risk signal

29 July, 2026

3 min read

vaccines don’t trigger flares in patient with autoimmune disease — German claims study delivers reassurance

27 July, 2026

2 min read

Literature update ViVa week 29-2026

23 July, 2026

13 min read

The PPP of dengue vaccines: past, present, and pipeline

23 July, 2026

12 min read

Needle-free pan-sarbecovirus vaccine clears phase 1 safety milestone, but broad protection remains unproven

21 July, 2026

2 min read

Vaccines return $16 for every $1 invested, but the era of dramatic cost savings may be fading

21 July, 2026

2 min read

Dual influenza subtype positivity is linked to more severe pneumonia, but is it true co-infection or a dataset artifact?

21 July, 2026

2 min read

Old epilepsy drug repurposed as a low-cost metabolic vaccine booster increases T-cell responses 10-fold in a human trial

21 July, 2026

2 min read

ViVa news week 29 (July 20, 2026)

20 July, 2026

6 min read

Global child vaccination rates tick up, but millions still left Unprotected — WHO/UNICEF

16 July, 2026

3 min read

Measles masquerading as “just fever” in nearly a third of Tanzanian cases — no rash, no suspicion, worse outcomes, and a diagnosis missed for two months

15 July, 2026

2 min read

All Articles

GHP News Latest Science

Literature update ViVa week 38-2026

1. Three doses help—but immunosuppressed patients remain a COVID-19 high-risk group Summary: In a systematic review and random-effects meta-analysis, Stadler and colleagues searched PubMed, Scopus, and Embase through...

23 September, 2026

12 min read

Latest Science Outbreak Countries

ViVa 38– Global outbreak status (23rd September 2026)

Ebola disease (Bundibugyo virus) — Democratic Republic of the Congo: As of September 19, the DRC had reported 7,672 confirmed cases and 3,699 deaths; 58 cases and 23 deaths were newly reported in the preceding day...

23 September, 2026

3 min read

Latest Science

Feature: The 2026 vaccine licenses: influenza drives a new platform era

The most revealing feature of vaccine licensure in 2026 is not a newly targeted pathogen. It is the concentration of innovation around familiar respiratory threats: seasonal influenza and COVID-19. Four notable...

23 September, 2026

11 min read

GHP News Outbreak Countries

ViVa 37– Global outbreak status (16th September 2026)

As of September 15, 2026, the largest acute international outbreak is Bundibugyo Ebola virus disease in the Democratic Republic of the Congo (DRC), which continues to expand rapidly. Other active priorities include...

16 September, 2026

6 min read

GHP News

Literature update ViVa week 37-2026

1. More potential rabies exposures, more PEP errors: CDC health alert Summary: The CDC issued a Health Alert Network advisory on September 10, 2026, following increased reports of human exposure to rabid or potentially...

16 September, 2026

5 min read

Latest Science

ViVa 37 Feature: Influenza vaccines for the 2026–2027 respiratory season

For decades, seasonal influenza vaccines were produced primarily in embryonated eggs. Live attenuated influenza vaccine (LAIV), administered intranasally, became available in 2003. Over the past decade, additional...

16 September, 2026

11 min read

Latest Science

Literature update ViVa week 36-2026

1. Firearms remain America’s defining youth mortality crisis Summary: In this correspondence responding to a 2026 research letter, Bleyer, Liu, and Thomas analyzed 2024 CDC WONDER mortality data for U.S. residents aged...

9 September, 2026

8 min read

Latest Science Outbreak Countries

ViVa 36– Global outbreak status (09th September 2026)

Period covered: September 1–8, 2026. The most consequential event remains the rapidly expanding Bundibugyo Ebola outbreak in the Democratic Republic of the Congo (DRC); other priority signals are ongoing mpox...

9 September, 2026

5 min read